Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease - Wikidata - wikimedia - TriplyDB

Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease

Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease

http://www.wikidata.org/entity/Q35761447

about

Imaging of intestinal fibrosis: current challenges and future methods Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases CT-P13: design, development, and place in therapy Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium.Predicting response to Anti-TNF Agents for the treatment of crohn's disease.Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn's disease Molecular imaging in cancer treatment.Worms, flies and four-legged friends: the applicability of biological models to the understanding of intestinal inflammatory diseases.In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease.Cyclosporine A regulates pro-inflammatory cytokine production in ulcerative colitis.Evidence of functional cross talk between the Notch and NF-κB pathways in nonneoplastic hyperproliferating colonic epithelium.In vivo single-photon emission computed tomography imaging of apoptosis in Crohn's disease and anti-tumour necrosis factor therapy.Mode of function of biological anti-TNF agents in the treatment of inflammatory bowel diseases.Infliximab therapy for pediatric Crohn's disease.CD4(+) T-cell subsets in intestinal inflammation Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Nuclear imaging of autoimmunity: focus on IBD and RA.Phosphatidylserine targeting for diagnosis and treatment of human diseases.SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?Clinical applications in molecular imaging.Mechanisms of action of anti-tumor necrosis factor α agents in Crohn's disease.Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation.Imaging apoptosis in the eye.The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel Disease.Anti-TNF-α therapies for the treatment of Crohn's disease: the past, present and future.Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease.Biomarkers in Search of Precision Medicine in IBD.Extrapolation and Interchangeability of Infliximab and Adalimumab in Inflammatory Bowel Disease.Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor α neutralization.Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis.Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V.Role of genetics in prediction of disease course and response to therapy.TNFalpha blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats.Therapeutic Targets for Emerging Biologic Therapies in IBD.

P2860

Q26740545-B43B3299-EC41-4223-8A8A-9292FCD8E0C2 Q28067245-D4BBD8A1-25AD-468F-992B-CBB717EF43B3 Q33803728-915A7F42-BE42-497D-B7EB-F04848306226 Q34003160-725B61C9-82B5-4000-82F0-C646E88889C3 Q34408990-9A6C7B14-359E-4C80-8BB1-FD84CC6ACB6D Q34449843-4F84EE56-8BF3-4D5D-AF14-A460679ED251 Q34496670-1A78F79D-6AC5-453E-BDE5-9FB130FCCB28 Q35070715-CA337B93-565A-4FB9-90B0-2C8410839F33 Q35100867-2FDAA46C-62B5-4DC7-8C04-F0F892B85102 Q35231496-E2457416-C751-4654-AD70-8D68AC40C159 Q36593483-6AB01C2F-6D7A-4746-902C-015E3AF25A9B Q36763435-00411247-3815-4902-A5D1-72D784D8361A Q36897403-21F02395-C63C-466E-BCAD-4167E489E68E Q37012073-072F1C80-61F4-488A-A420-D4181EEC03C6 Q37076943-D1699A84-6919-4B07-AD93-49C225316484 Q37281018-207FCF04-B216-47A0-9F0C-406C45A5F1BF Q37345896-5D320E10-E936-4EB8-BD41-D208BA1E527F Q37730107-CC4599E5-7BE9-42D9-97F2-C69E371862CE Q37741860-B908FE5B-4CFC-46F9-9439-E05C9EE02393 Q37746356-30F301E2-C89B-4083-B524-963F9E7029CC Q37762230-4C635289-CAE6-47C0-8044-FA567F2A78C2 Q37815405-30312E08-6C46-448B-8A1C-D135D4CCCA73 Q38099727-F15DECC6-4A9C-42FC-8530-A81D07FF2762 Q38223249-69E1CA0E-440F-482E-A742-050539445E66 Q38375518-1080E36E-8A23-42A1-954F-E3FAE6C89332 Q38424224-A683885F-16E1-4107-91EC-6573CEE19F05 Q38582765-D757CB42-F6D8-4674-A7BA-23FC87FE7309 Q38652276-4D0D068A-6354-4DC2-B73A-BF752E873F74 Q38660544-6F30FC7C-37FA-49AF-8946-93B190F5E6BF Q38850512-34E7C15F-DBF9-4114-A30E-1F3BA3971168 Q38964878-092E8164-6FD2-4BCB-B035-62B3A59A5813 Q38977625-5A7146E0-F380-4E6B-983D-B14CB3DA40C3 Q39008712-4026192B-5599-4885-AD0F-ACA7A2E7610D Q39018436-82E4B69B-9977-418A-B246-B26A447B529B Q39350996-4890DC7D-87E0-4301-8E96-F20F847E1FA6 Q39817421-2099E760-6311-47BC-A4C9-907071432069 Q39954724-78110980-D927-4EBF-9AE3-82F856D3F0ED Q40884136-75862F39-6236-4945-B3AE-A8120B17212C Q41861964-3050487C-74F1-49BB-95F0-AD8920BAB2B1 Q45839795-6A6615DC-A084-4925-AB06-6C6ABC5306EF

P2860

Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease

http://www.wikidata.org/entity/Q35761447

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Prediction of antitumour necro ...... patients with Crohn's disease

@ast

Prediction of antitumour necro ...... patients with Crohn's disease

@en

type

label

Prediction of antitumour necro ...... patients with Crohn's disease

@ast

Prediction of antitumour necro ...... patients with Crohn's disease

@en

prefLabel

Prediction of antitumour necro ...... patients with Crohn's disease

@ast

Prediction of antitumour necro ...... patients with Crohn's disease

@en

P1433

Q35761447-5F5DFF25-66A1-4CFE-BC47-2151E73727C5

P1476

Q35761447-F8C8E622-925B-4237-BD3B-C8A1F0E75FAB

P2093

Q35761447-2167B78F-FC95-4B0C-8420-7C05AB72909E

Q35761447-4718BA76-FB6C-4B41-B61F-442600280518

Q35761447-5B154CCF-2A9E-4132-B33E-5B61099DD3C3

Q35761447-61D89B16-28FC-484D-9D03-342DC8CE9C9A

Q35761447-67D182A1-7BC6-40A1-B717-F8CF428900A2

Q35761447-9D479460-B930-4D01-8042-12F6B10EBCF5

Q35761447-B0A680DE-56C9-4DE4-8B46-E8FBF26785CF

Q35761447-C2CE77E7-EFC2-4DAD-81D1-87F622D77387

P2860

Q35761447-01D63D18-B58A-4A18-B2E2-A25A78E034B3

Q35761447-039D79D3-2A1C-4429-9341-2AA6F6615901

Q35761447-0C63D69C-3B1B-4390-A27B-CD76445CB739

Q35761447-1111D797-B90D-4E93-966F-A0ACCC74DF3C

Q35761447-23C6009F-E786-4683-8DE5-121F60D4EB7C

Q35761447-2671C575-8D5F-46D8-89FF-EA5E80AF6A3F

Q35761447-405C3AC7-EEF2-4878-8620-0C014C59C3E7

Q35761447-40DA811D-540E-4D15-A41C-DCD2A6D6FB16

Q35761447-4814852B-A941-499C-A2C3-5DB6D37CD6AE

Q35761447-48DC50AC-B975-4D9A-8507-F5FA2F09EA7F

P304

Q35761447-C47A9EC3-BC96-460B-B932-720DA0582252

P31

Q35761447-3BB38811-1FDF-4185-9D44-EE5229637B5D

P356

Q35761447-06D8FDC9-302A-45BF-886F-2D2DB33A04A7

P407

Q35761447-045F9EF5-A30F-4107-920B-D5F559C290B5

P433

Q35761447-D1D31053-8E9A-4F52-90CE-FAB45858F3CC

P478

Q35761447-9E6027DE-A75B-45CB-B70F-0A1BF6C89398

P50

Q35761447-85E803C1-75F7-4977-8E7D-DF711EDDDC85

P577

Q35761447-5C09060C-81AE-410D-A4C6-329B9396A1D3

P5875

Q35761447-A4CB59C0-65AC-4234-BEA1-71FA10983E7E

P698

Q35761447-B738E3ED-7760-4C8A-BD0F-2EF6E0091A20

P921

Q35761447-7DAEE5BE-67AA-46BA-A4D0-1E6F07BE4608

P932

Q35761447-B435DC88-E8DF-4037-A505-FA43E35797B0

P356

GUT.2006.105379

P1433

P1476

Prediction of antitumour necro ...... patients with Crohn's disease

@en

P2093

Anje A te Velde

http://www.w3.org/2001/XMLSchema#string

Daniël W Hommes

http://www.w3.org/2001/XMLSchema#string

Fibo J W ten Cate

http://www.w3.org/2001/XMLSchema#string

Jan M H Van den Brande

http://www.w3.org/2001/XMLSchema#string

Roelof J Bennink

http://www.w3.org/2001/XMLSchema#string

Sander J H van Deventer

http://www.w3.org/2001/XMLSchema#string

Tamara C Koehler

http://www.w3.org/2001/XMLSchema#string

Zuzana Zelinkova

http://www.w3.org/2001/XMLSchema#string

P2860

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis.

Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab.

Tumor necrosis factor: biology and therapeutic inhibitors.

Monitoring apoptosis in real time.

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease

The imaging of apoptosis with the radiolabeled annexin V: optimal timing for clinical feasibility.

The pathophysiology of tumor necrosis factors.

P304

509-517

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2006.105379

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Maikel P Peppelenbosch

P577

2006-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6715018

http://www.w3.org/2001/XMLSchema#string

P698

17082252

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

1856870

http://www.w3.org/2001/XMLSchema#string